State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
NCT06994676 Phase 1
Recruiting
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Condition
High-risk Myelodysplastic Syndrome
Enrollment
72 pts
Location
United States
Sponsor
Crossbow Therapeutics, Inc.
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
880 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT03965143 N/A
Recruiting
Talus Replacement Registry
Condition
Avascular Necrosis of the Talus
Enrollment
50 pts
Location
United States
Sponsor
Kyle Schweser MD
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT03966027 N/A
Recruiting
Immediate Vs. Delayed Weight Bearing Postoperative Protocol in Diabetic Ankle Fr...
Condition
Ankle Fractures
Enrollment
25 pts
Location
United States
Sponsor
Kyle Schweser MD
NCT05645380 Phase 2
Recruiting
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Condition
Triple Negative Breast Cancer
Enrollment
139 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04877288 Phase 3
Recruiting
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent ...
Condition
Renal Allograft Recipients
Enrollment
102 pts
Location
United States, Argentina, Belgium
Sponsor
Bristol-Myers Squibb
NCT07287124 N/A
Recruiting
A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a To...
Condition
Hearing Loss, Bilateral Sensorineural
Enrollment
56 pts
Location
United States
Sponsor
Cochlear
NCT07195734 Phase 2
Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
180 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06830109 Phase 2
Recruiting
Nasal Obstruction With Oxymetazoline and Corticosteroids
Condition
Nasal Obstruction
Enrollment
80 pts
Location
United States
Sponsor
Washington University School o
NCT06625775 Phase 1
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
392 pts
Location
United States, Australia, France
Sponsor
TheRas, Inc., d/b/a BBOT (Brid
NCT02914067 N/A
Recruiting
Cognitive Biomarkers in Pediatric Brain Tumor Patients
Condition
Childhood Brain Tumor
Enrollment
200 pts
Location
United States
Sponsor
Washington University School o
NCT06785636 Phase 1, Phase 2
Recruiting
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetat...
Condition
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Enrollment
252 pts
Location
United States
Sponsor
Pathos AI, Inc.
NCT05434598 N/A
Recruiting
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profil...
Condition
Whole Genome Sequencing
Enrollment
60 pts
Location
United States
Sponsor
Washington University School o
NCT05843643 Phase 3
Recruiting
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacit...
Condition
Systemic Lupus Erythematosus
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT06783309 Phase 1, Phase 2
Recruiting
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Wit...
Condition
Type 1 Diabetes Mellitus
Enrollment
72 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT05362721 N/A
Recruiting
PV Loop & Coarctation Study
Condition
Coarctation of Aorta
Enrollment
20 pts
Location
United States
Sponsor
University of Minnesota
NCT06848348 Phase 2
Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced ...
Condition
Chemotherapy Induced Neuropathic Pain
Enrollment
200 pts
Location
United States
Sponsor
Dogwood Therapeutics Inc.
NCT06065748 Phase 3
Recruiting
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestran...
Condition
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Enrollment
1,050 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT06319820 Phase 3
Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in...
Condition
Non-Muscle Invasive Bladder Neoplasms
Enrollment
641 pts
Location
United States, Argentina, Austria
Sponsor
Janssen Research & Development
NCT07133308 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With ...
Condition
Alopecia Areata
Enrollment
355 pts
Location
United States, Canada
Sponsor
Sun Pharmaceutical Industries,
NCT06883240 N/A
Recruiting
An Observational Study of Participants With Type 3 Von Willebrand Disease on Pro...
Condition
Von Willebrand Disease, Type 3
Enrollment
40 pts
Location
United States, Belgium, Canada
Sponsor
Hoffmann-La Roche
NCT05656261 N/A
Recruiting
APOL1 Genetic Testing in African Americans
Condition
Genetic Predisposition
Enrollment
600 pts
Location
United States
Sponsor
St. Louis University
Page 11 of 11 — 275 trials total